The ACC/AHA Task Force has created a focused update process to revise existing guideline recommendations for stable ischemic heart disease based on evolving data and new evidence.
Keeping pace with emerging evidence is an ongoing challenge to timely development of clinical practice guidelines. In an effort to respond promptly to new evidence, the American College of Cardiology (ACC)/American Heart Association (AHA) Task Force on Practice Guidelines (Task Force) has created a “focused update” process to revise the existing guideline recommendations that are affected by evolving data or opinion. New evidence is reviewed in an ongoing manner to respond quickly to important scientific and treatment trends that could have a major impact on patient outcomes and quality of care.
Fihn et al. (Fri,) conducted a review in Stable ischemic heart disease. The ACC/AHA Task Force has created a focused update process to revise existing guideline recommendations for stable ischemic heart disease based on evolving data and new evidence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: